Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma With Comparison to Tumors of Similar Histology

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)63502-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Epidermal Growth Factor Receptor in Breast Cancer. Comparison With Non Malignant Breast Tissue

British Journal of Cancer
Cancer ResearchOncology
1993English

Correlates and Determinants of Nuclear Epidermal Growth Factor Receptor Content in an Oropharyngeal Cancer Tissue Microarray

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Mutant Epidermal Growth Factor Receptor in Benign, Borderline, and Malignant Ovarian Tumors

Clinical Cancer Research
Cancer ResearchOncology
2008English

Clinical Significance of the Mutant Epidermal Growth Factor Receptor "ΔEGFR" in Astrocytic Tumors

Japanese Journal of Neurosurgery
SurgeryNeurology
2003English

Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor Tyrosine Kinase Receptors in Synovial Sarcoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Epidermal Growth Factor Receptor in Human Glioma

Journal of Neurosurgery
SurgeryNeurology
1989English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy